Skip to main content
Top
Published in: Rheumatology International 2/2024

23-12-2023 | Vasculitis | Case Based Review

Pseudoxanthoma elasticum veiled as vasculitis: shedding light on an uncommon disorder and an in-depth review of the literature

Authors: Rand Murshidi, Fatima Alnaimat, Salameh Al-Halaseh, Suzan Hanandeh, Salsabiela Bani Hamad, Maram Abdaljaleel, Nosaiba Al Ryalat

Published in: Rheumatology International | Issue 2/2024

Login to get access

Abstract

Pseudoxanthoma Elasticum (PXE) is a rare genetic disorder caused by an autosomal recessive mutation in the ABCC6 gene. It manifests with distinctive clinical symptoms impacting the skin, eyes, and cardiovascular system, along with an elevated risk of cardiovascular diseases. We present a case of a 34-year-old male patient who was initially referred to the rheumatology clinic for evaluation due to suspected large vessel vasculitis. The patient's primary complaint was severe hemifacial pain radiating to the neck and upper limb. Radiological imaging studies unveiled substantial vascular narrowing and collateral vessel formation, prompting further investigation to exclude systemic vasculitis. Intriguingly, the patient also exhibited cutaneous manifestations, which were later confirmed via skin biopsy as consistent with PXE. An ophthalmological examination further revealed the presence of the classic PXE findings of angioid streaks. Given the rarity of PXE and its multifaceted clinical presentation, it can be particularly challenging to diagnose and manage. As such, cases like the one presented here may necessitate a referral to a rheumatologist for evaluation of potential systemic involvement. To provide a comprehensive perspective on PXE, we conducted a systematic review of case reports published in the past decade in English, collected from PubMed, Scopus, and the Directory of Open Access databases. The analysis of these cases will be discussed to shed light on the diversity of PXE’s clinical features and the diagnostic and management dilemmas it poses and to facilitate ongoing exploration and research into this intricate condition, ultimately leading to improved care for individuals affected by PXE.
Literature
26.
go back to reference Lefthériotis G, Abraham P, Corre YL et al (2011) Relationship between ankle brachial index and arterial remodeling in pseudoxanthoma elasticum. J Vasc Surg 54(5):1390CrossRefPubMedPubMedCentral Lefthériotis G, Abraham P, Corre YL et al (2011) Relationship between ankle brachial index and arterial remodeling in pseudoxanthoma elasticum. J Vasc Surg 54(5):1390CrossRefPubMedPubMedCentral
30.
go back to reference Choe Y, Shin CH, Lee YA, Kim MJ, Lee YJ. (2022) Case report and review of literature: autosomal recessive hypophosphatemic rickets type 2 caused by a pathogenic variant in ENPP1 gene. Front Endocrinol.13. https://www.frontiersin.org/articles/https://doi.org/10.3389/fendo.2022.911672. Accessed 18 July 2023 Choe Y, Shin CH, Lee YA, Kim MJ, Lee YJ. (2022) Case report and review of literature: autosomal recessive hypophosphatemic rickets type 2 caused by a pathogenic variant in ENPP1 gene. Front Endocrinol.13. https://​www.​frontiersin.​org/​articles/​https://​doi.​org/​10.​3389/​fendo.​2022.​911672. Accessed 18 July 2023
Metadata
Title
Pseudoxanthoma elasticum veiled as vasculitis: shedding light on an uncommon disorder and an in-depth review of the literature
Authors
Rand Murshidi
Fatima Alnaimat
Salameh Al-Halaseh
Suzan Hanandeh
Salsabiela Bani Hamad
Maram Abdaljaleel
Nosaiba Al Ryalat
Publication date
23-12-2023
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 2/2024
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-023-05509-w

Other articles of this Issue 2/2024

Rheumatology International 2/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine